PROTEA study: a protocol for a randomised controlled trial evaluating the efficacy, immune effects and cost-effectiveness of oral bacterial lysate therapy to protect moderate-late preterm infants from respiratory tract infections and wheezing
ERJ Open Res. 2025 May 27;11(3):00591-2024. doi: 10.1183/23120541.00591-2024. eCollection 2025 May. ABSTRACT Infants, children and adults born moderate-late preterm (after 30-36 weeks of pregnancy) are …